Back

The I4RON-HF study, Intravenous Iron Isomaltoside for Inpatients veRsus Outpatient Asians with Heart Failure

27 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Chronic heart failure - New treatments and trials Comorbidities ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Tjen Jhung Lee

National Heart Institute, Kuala Lumpur (Malaysia)

4 More presentations in this session

Presentation thumbnail
The effects of combined hyperbaric oxygenation and erythropoietin therapy in treatment of heart failure
Professor P. Mitrovic (Belgrade, RS)
Slides
Presentation thumbnail
Myeloperoxidase as therapeutic target in HFpEF
Doctor S. Lejeune (Brussels, BE)
Abstract Slides
Presentation thumbnail
First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function
Doctor H. Bahrami (Herlev, DK)
Abstract Slides
Presentation thumbnail
Chronic mitochondrial fusion promotor as a novel pharmacological intervention to alleviate left ventricular dysfunction in rats with chronic myocardial infarction
Doctor C. Maneechote (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - New treatments and trials

The Event

Event poster

ESC Congress 2022

27 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Presentation
Spectrum of non-cardiac comorbidities
thumbnail
Congress Presentation
Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources